Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.

Current opinion in hematology - 1 Mar 2009

Zang Dae Young, Deeg H Joachim

Abstract excerpt

PURPOSE OF REVIEW: Hematopoietic cell transplantation (HCT) offers potentially curative therapy for patients with myelofibrosis. What is the current status? RECENT FINDINGS: Changes in transplant strategies allow offering HCT to patients who, because of age or comorbid conditions, were not considered transplant candidates in the past. The omission of high-dose total body irradiation, adjusting doses of busulfan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Hematopoietic Stem Cell Transplantation
Share to Janus Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Primary Myelofibrosis

Share to Prognosis

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 19468277
DOI: 10.1097/MOH.0b013e3283257ab2
PMCID: PMC2687524

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.PMID 19468277Read ↗

Controversies and dilemmas in allogeneic transplantation for myelofibrosis.Semantic proximity Read ↗

Allogeneic stem cell transplantation for myelofibrosis in 2012.Semantic proximity Read ↗

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelofibrosis: A Practical Review.Semantic proximity Read ↗

Allogeneic haematopoietic cell transplantation for myelofibrosis: a real-life perspective.Semantic proximity Read ↗

Safety and outcome of allogeneic stem cell transplantation in myelofibrosis.Semantic proximity Read ↗

Allogeneic Stem Cell Transplant for Myelofibrosis and Myelodysplastic Syndromes: A Contemporary Review.Semantic proximity Read ↗

Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?Semantic proximity Read ↗

From palliation to epigenetic therapy in myelofibrosis.Semantic proximity Read ↗

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cellsSemantic proximity Read ↗

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.Semantic proximity Read ↗

Hematopoietic Cell Transplantation for Myelodysplastic Syndromes.Semantic proximity Read ↗

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decadesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.